GFS Advisors, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.

Quarter-by-quarter ownership
GFS Advisors, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$862,000
-10.6%
32,023
-0.0%
0.13%
-37.4%
Q2 2023$964,000
-9.8%
32,032
-3.1%
0.21%
-13.0%
Q1 2023$1,069,000
+10.8%
33,055
-1.8%
0.25%
+13.4%
Q4 2022$965,000
+22.8%
33,654
+3.3%
0.22%
+14.8%
Q3 2022$786,000
-11.5%
32,576
+0.5%
0.19%
-5.0%
Q2 2022$888,000
-27.3%
32,427
+1.8%
0.20%
-22.6%
Q1 2022$1,221,000
+22.0%
31,843
+1.9%
0.26%
+55.8%
Q4 2021$1,001,000
+15.5%
31,264
+6.3%
0.16%
-12.2%
Q3 2021$867,000
+1.9%
29,407
+17.5%
0.19%
-2.1%
Q2 2021$851,000
+19.5%
25,037
+14.3%
0.19%
+15.7%
Q1 2021$712,000
+7.6%
21,902
+19.2%
0.17%
-4.6%
Q4 2020$662,000
-2.8%
18,379
+5.7%
0.17%
-15.9%
Q3 2020$681,000
+29.2%
17,391
+21.1%
0.21%
+27.0%
Q2 2020$527,000
+92.3%
14,358
+20.9%
0.16%
+89.5%
Q1 2020$274,000
-19.6%
11,877
+1.8%
0.09%
-3.4%
Q4 2019$341,000
+8.9%
11,663
-0.4%
0.09%
+2.3%
Q3 2019$313,000
-12.1%
11,714
-15.9%
0.09%
-13.9%
Q2 2019$356,00013,9230.10%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders